STAAR Surgical (STAA) rose 4.1% as the shareholder vote on its planned sale to Alcon (ALC) was adjourned.
Alcon (ALC) exercised its right under the merger agreement to require STAAR to adjourn the special meeting, according to a statement on Friday. The special meeting is adjourned until Jan.6.
The adjournment comes as several large shareholders, including Broadwood Partners, STAAR's biggest holder with a 30% stake, have come out against the transaction, even after the deal price was raised to $30.75 from $28.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.